T2DM is categorized as a metabolic disease marked by two major physiological defects: resistance to insulin and beta cell malfunction, which do not arise simultaneously. Insulin resistance is described as a loss of sensitivity to insulin by target tissues, while beta cell dysfunction is described as inadequate insulin production by pancreatic beta cells to sustain normal glucose levels. The gene discussed is INS; the disease is metabolic disease.